Across TCGA pan-cancer cohorts, TRAIP Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated TRAIP data layer compared with 28 for mass-spec protein.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher TRAIP Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated TRAIP expression acts as an unfavorable survival marker.

CESC and UCEC are the cancer types where TRAIP Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	DFS	Median	II,III,IV	0.053	0.786	<.001	36	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: TRAIP tumor-vs-normal RNA expression · all TRAIP data types